Skip to content

To study the efficacy of Zinc bio fortified wheat based food in improving low Zinc status in Indian school children

Efficacy of Zn bio fortified wheat in improving Zn status in Indian school children with low Zn status: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/06/005913
Enrollment
270
Registered
2015-06-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Biofortified wheat flour with 60 ppm zinc: chapathi made of biofortified wheat flour for lunch (1 meal/day) for 6 months. Intervention2: Regular fortified wheat flour with 60 ppm zinc:

Sponsors

ETH Eidgenossische Technische Hochschule Zurich
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: zinc deficient otherwise healthy Indian school children

Exclusion criteria

Exclusion criteria: 1. Severe anemia (Hb 2. Consumption of a supplement or dietary supplement containing Zn. 3. Use of drugs that affect the metabolism of Zn, including reducing absorption or increasing excretion; for example tuberculosis medications (ethambutal and isoniazides), drugs used as treatment for entamoeba hystolica (diiodohydroxyquin), drugs that reduce stomach acidity (H2 blockers and proton pump inhibitory), antidepressants (nialamide and isocarboxazid), anti-inflammatory drugs (corticosteroids), diuretics (thiazides), aspirin, penicillamine and alcohol. 4. Suffering from a chronic disease affecting the metabolism of Zn, such as kidney disease or chronic gastrointestinal problems, as for example enter colitis, ulcers and other diseases disturbing the absorption of micro nutrients.

Design outcomes

Primary

MeasureTime frame
Plasma zinc status, C reactive proteins, alpha 1- acid glycoprotein,Timepoint: Baseline Mid point ( 1- 5 months) endline(6 months) Followup (8 months)

Secondary

MeasureTime frame
Hemoglobin, plasma ferritinTimepoint: Baseline Mid point ( 1- 5 months) endline(6 months) Followup (8 months)

Countries

India

Contacts

Public ContactDr Anura Kurpad

St. Johns Research Institute

a.kurpad@sjri.res.in080-25532037

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 10, 2026